Biden Administration Rescinds Trump Administration Insulin …
Oct 26, 2021 · One of the final healthcare actions made by the Trump Administration has been rescinded by the Biden Administration. On December 23, 2020, the Trump Administration finalized a rule that directed the Department of Health and Human Services (HHS) to take action to require that federally qualified health centers (FQHCs) make insulin and injectable epinephrine available to certain patients at 340B ...
ACA Section 1557: A Comprehensive Overview for Healthcare …
Jul 10, 2024 · On a recent evening, the Medical Society of New Jersey and Policymed.com hosted a pivotal webinar to discuss the 2024 final rule for ACA Section 1557.This regulation, which came into effect on July 5, 2024, addresses non-discrimination in healthcare and poses significant implications for healthcare providers.
DEA and HHS Extend Telehealth Flexibilities for Controlled …
Jan 10, 2024 · The rule’s publication drew significant opposition from the provider stakeholder community, with the DEA receiving more than 38,000 comments in response, most of which scrutinized DEA’s perceived shortsightedness and burdensome requirements for typical prescribing relationships.
PhRMA Announces Updated Code on Interactions with Health …
On August 6, 2021, the Pharmaceutical Research and Manufacturers of America (PhRMA) released its updated Code on Interactions with Health Care Professionals, a voluntary code of ethics that applies to pharmaceutical company interactions with United States health care professionals. As a member of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), the PhRMA ...
November 21, 2024 – Policy & Medicine
4 days ago · Legal, Regulatory, and Compliance Issues. The United States Department of Health and Human Services (HHS) recently proposed a rule that would require HHS contractors to use…
November 22, 2024 – Policy & Medicine
3 days ago · Legal, Regulatory, and Compliance Issues. On August 28, as part of its Fiscal Year 2025 Hospital Inpatient Prospective Payment System (IPPS) Final Rule, the Centers for…
November 20, 2024 – Policy & Medicine
5 days ago · Legal, Regulatory, and Compliance Issues. Maryland’s Prescription Drug Affordability Board (PDAB) released its draft action plan for establishing upper payment limits…
November 1, 2024 – Policy & Medicine
Nov 1, 2024 · Legal, Regulatory, and Compliance Issues. Recently, the United States Food and Drug Administration (FDA) issued a draft guidance, Integrating Randomized Controlled Trials…
November 19, 2024 – Policy & Medicine
5 days ago · Legal, Regulatory, and Compliance Issues. The nation’s three largest drug distributors – McKesson Corp, Cardinal Health Inc, and Cencora Inc – recently agreed to pay $300…
Policy & Medicine – Legal, Regulatory, and Compliance Issues
Legal, Regulatory, and Compliance Issues. Maryland’s Prescription Drug Affordability Board (PDAB) released its draft action plan for establishing upper payment limits (UPLs) for drugs identified as causing (or likely to cause) affordability shortages.